Littleton, CO November 25, 2014
CereScan, a national leader in functional brain diagnostics and molecular imaging, was selected as an Innovation Partner and invited to present at the Cavendish Global Health Impact Forums that took place November 10-13th at Oxford University in the UK and will take place April 27-30, 2015 in San Diego. The Health Impact Forums help family offices and foundations develop and implement their individual pro-social impact investing, grant-giving, and philanthropy programs within the health and life sciences. To accomplish this mission, the Forums showcase presentations and panel discussions by leading scientists, accomplished healthcare delivery professionals, health-policy experts and private-sector companies engaged in developing innovations with the potential for transformational impact on disease prevention, diagnosis and treatment. Michael Moffat, Cavendish co-founder and President explains, “With the help of our expert advisors, we conduct a global search of research institutions and private-sector companies in order to identify organizations that meet the required standard of excellence. CereScan’s advanced technologies and pioneering research clearly qualified them as an Innovation Partner and we are delighted that they have joined the Cavendish family.”
“We are honored to be selected as an Innovation Partner and to present our leading-edge research at these unique events. It is further recognition of our innovative approaches in the brain health arena,” said Dr. Richard Fort, CereScan President & COO. “We welcome the opportunity to interact with many of the world’s leading scientific minds, thought-leaders and philanthropic families who are dedicated to the common cause of improving the health and lives of people around the world.”
At the November Health Impact Forum, CereScan presented preliminary results of a research program, the Invisible Brain Injury Project, aimed at assessing a novel treatment for traumatic brain injuries (TBIs). This research program, funded by the Tug McGraw Foundation, recruited veterans who served in the Middle East conflicts and suffered TBIs. The aim of this project is to identify effective treatments of TBI and accelerate their adoption in brain healthcare. Final results of the IBIP will be presented at the next Cavendish Health Impact Forum in April, 2015 in San Diego.
CereScan combines state-of-the-art SPECT and PET/CT brain imaging technology with a patient-centered model of care to provide the highest level of neurodiagnostics anywhere. Using quantitative, functional brain imaging, advanced imaging software, and an extensive library of clinical data, the CereScan medical team provides physicians with unmatched objective diagnostic information. CereScan helps patients and their physicians better understand the biological basis of their conditions. In a variety of legal settings, CereScan provides objective evidence to attorneys and their clients regarding traumatic and toxic brain injuries. For brain therapy researchers, CereScan provides independent pre- and post-treatment measures of organic changes in the brain along with measures of symptoms related to the brain disorder of interest. For more information, please call (866) 722-4806 or visit www.CereScan.com.
About Cavendish Global
Cavendish Global consists of over 150 leading family offices and foundations from around the world with combined assets of over $190 billion who share a passion for pro-social endeavors within health and the life sciences. The Cavendish Global Health Impact Forums provide family offices with a discrete, peer-to-peer knowledge expansion and relationship building environment, combined with the information and educational resources required by foundations actively seeking to accelerate technological innovation and health access through sustainable philanthropy, grant-making and impact investing. The Forum is also an opportunity for family offices to champion and share information on projects and organizations, which they are passionate about with other family offices from around the world. For more information, please visit http://cavendishglobal.com.